Showing results (351-360 of 413) with videos related to

Sort By:
Pageof 42
Mucosal Immunology|August 28, 2009
Link between allergic asthma and airway mucosal infection suggested by proteinase-secreting household fungiP Porter, S C Susarla, S Polikepahad, et al.
Antiviral Research|June 25, 2023
Late remdesivir treatment initiation partially protects African green monkeys from lethal Nipah virus infectionEmmie de Wit, Brandi N Williamson, Friederike Feldmann, et al.
Scientific Reports|April 20, 2023
Effect of remdesivir post-exposure prophylaxis and treatment on pathogenesis of measles in rhesus macaquesNadine A Peart Akindele, Laharika Dasharath Katamoni, Jacqueline Brockhurst, et al.
Clinical Genitourinary Cancer|February 25, 2014
Role of maximal endoscopic resection before cystectomy for invasive urothelial bladder cancerAndrew C James, Franklin C Lee, Jason P Izard, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 26, 2005
Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activityRichard H P Porter, Georg Jaeschke, Will Spooren, et al.
Clinical Immunology (Orlando, Fla.)|December 17, 2002
Evaluation of antigen-based heteropolymer for treatment of systemic lupus erythematosus in a nonhuman primate modelSteven E Pincus, Nadya Lukacher, Nehal Mohamed, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 2, 2014
Ceramides mediate cigarette smoke-induced metabolic disruption in miceMikayla O Thatcher, Trevor S Tippetts, Michael B Nelson, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|November 13, 2008
A regional health information exchange: architecture and implementationMark E Frisse, Janet K King, Will B Rice, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2024
SARS-CoV-2 resistance analyses from the Phase 3 PINETREE study of remdesivir treatment in nonhospitalized participantsLauren Rodriguez, Hery W Lee, Jiani Li, et al.
Pageof 42